journal article·2017-11-17Open access

Hydrophobically modified polyethylenimine-based ternary complexes for targeting brain tumor: stability, in vitro and in vivo studies

Brahmanand Dube, Abhijeet Pandey, Ganesh Joshi, Krutika Sawant

Abstract

Hydrophobic modification of low molecular weight polyethylenimine (PEI 2 kDa) by cholic acid (ChA) was done to obtain PEI2-ChA. The nanoplexes of PEI2-ChA with gWIZ-GFP demonstrated increase transfection efficiency (∼27%) in NT8e cell lines. The cell-cycle analysis of NT8e cells (p53 mutant) treated with transferrin containing nanoplexes showed increased apoptosis of cells. In vitro protein expression revealed expression of exogenous p53 protein. In vivo imaging of mice showed localized signal for GFP protein in brain region. The tumors of mice treated with transferrin containing nanoplexes of PEI2-ChA were ∼5 times smaller in size than the tumor of untreated animals.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Cancer Research and Treatments · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pharmacy Department, Faculty of Pharmacy, The M.S. University of Baroda, Kalabhavan, Vadodara, India;

Genetic Engineering Lab, ACTREC Tata Memorial Centre, Kharghar, Navi Mumbai, India

References (50)

Show source-provided references
1. 10.1016/j.actbio.2011.01.02710.1016/j.actbio.2011.01.027 ↗
2. 10.1593/tlo.0927410.1593/tlo.09274 ↗
3. 10.1371/journal.pone.004792710.1371/journal.pone.0047927 ↗
4. 10.3109/1061186X.2012.65524710.3109/1061186X.2012.655247 ↗
5. 10.1080/21691401.2016.120226010.1080/21691401.2016.1202260 ↗
6. 10.1016/j.jconrel.2006.02.01110.1016/j.jconrel.2006.02.011 ↗
7. 10.1007/s11999-009-0900-010.1007/s11999-009-0900-0 ↗
8. 10.1002/btpr.179910.1002/btpr.1799 ↗
9. 10.1126/science.286.5448.225610.1126/science.286.5448.2256 ↗
10. 10.1371/journal.pone.002294610.1371/journal.pone.0022946 ↗
11. 10.3109/1061186X.2011.58943510.3109/1061186X.2011.589435 ↗
12. 10.1038/sj.gt.330071710.1038/sj.gt.3300717 ↗
13. 10.1073/pnas.080176310510.1073/pnas.0801763105 ↗
14. 10.1021/nn100869j10.1021/nn100869j ↗
15. HosseiniHaji-Fatahaliha M · Artif Cells Nanomed Biotechnol · 2016 · 44 · 1051
16. 10.1016/j.colsurfb.2008.05.01210.1016/j.colsurfb.2008.05.012 ↗
17. 10.3109/13880209.2013.85381210.3109/13880209.2013.853812 ↗
18. 10.1089/1043034026035539210.1089/10430340260355392 ↗
19. 10.1080/21691401.2016.120225610.1080/21691401.2016.1202256 ↗
20. 10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y ↗
21. 10.1073/pnas.81.10.300510.1073/pnas.81.10.3005 ↗
22. 10.1002/jgm.55810.1002/jgm.558 ↗
23. 10.3109/02652048.2014.91372710.3109/02652048.2014.913727 ↗
24. Lemkine GF · Curr Opin Mol Ther · 2001 · 3 · 178
25. 10.1016/S0092-8674(00)81871-110.1016/S0092-8674(00)81871-1 ↗
26. 10.7150/thno.691410.7150/thno.6914 ↗
27. LiuCong J · Cell Growth Differ · 1999 · 10 · 677
28. 10.1016/j.molcel.2007.11.01610.1016/j.molcel.2007.11.016 ↗
29. 10.1016/S0304-3835(97)00241-310.1016/S0304-3835(97)00241-3 ↗
30. Mulherkar R. · Curr Sci · 2010 · 99 · 1542
31. 10.1073/pnas.223237910010.1073/pnas.2232379100 ↗
32. 10.1158/1535-7163.MCT-04-019610.1158/1535-7163.MCT-04-0196 ↗
33. 10.1021/bm060788z10.1021/bm060788z ↗
34. 10.1038/sj.gt.330074510.1038/sj.gt.3300745 ↗
35. 10.1166/jnn.2014.901410.1166/jnn.2014.9014 ↗
36. 10.1016/j.msec.2016.07.06610.1016/j.msec.2016.07.066 ↗
37. 10.1021/bc025529v10.1021/bc025529v ↗
38. 10.1038/mt.2013.23110.1038/mt.2013.231 ↗
39. 10.3109/21691401.2014.88544510.3109/21691401.2014.885445 ↗
40. 10.1007/s11095-011-0545-z10.1007/s11095-011-0545-z ↗
41. 10.1634/stemcells.22-1-210.1634/stemcells.22-1-2 ↗
42. 10.1016/0092-8674(92)90421-810.1016/0092-8674(92)90421-8 ↗
43. 10.1016/j.jss.2012.11.06110.1016/j.jss.2012.11.061 ↗
44. 10.1586/ecp.12.110.1586/ecp.12.1 ↗
45. 10.1002/jgm.18710.1002/jgm.187 ↗
46. 10.1016/j.intimp.2011.07.01410.1016/j.intimp.2011.07.014 ↗
47. 10.1038/nature0552910.1038/nature05529 ↗
48. 10.1038/nbt1096-124610.1038/nbt1096-1246 ↗
49. 10.1163/1568562036067422710.1163/15685620360674227 ↗
50. Zheng M · Pharm · 2012 · 8 · 2434